Nile Therapeutics shareholders intend to sell common stock in offering

Selling shareholders offer 7.75 million common shares at $0.75 apiece

By Devika Patel

Knoxville, Tenn., July 22 -Nile Therapeutics, Inc. reported that its shareholders plan to sell some of the company's stock in a Form S-1 filed Friday with the Securities and Exchange Commission.

The shareholders will sell 7.75 million common shares, which includes 2.75 million shares that will be issued after certain outstanding warrants are exercised, at $0.75 per share.

San Francisco-based Nile is a biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.